Ny finansiering ska ta Linköpingsbolagets sensorsystem vidare

Linköpingsbolaget Argus Eye, som utvecklar sensorsystem för biologiska läkemedel, har tagit in 32,5 miljoner kronor i en finansieringsrunda.

Index Pharmaceuticals rekryterar inför fas III-studie

Anställer Anders Bröijersén och Johan Levin till den kliniska utvecklingsorganisationen.

Swedish and Danish Life Science – are there still untapped synergies?

not be better. A one-day conference on ongoing collaborations, new directions and required future investment will held on April 2nd at Medicon Village in Lund.

Novavax is developing a vaccine candidate against Covid-19 and seasonal flu

A combined vaccine against both Covid-19 and seasonal flu is showing promising results in studies, according to the American drug developer Novavax. The adjuvan...

Event om biologiska läkemedel fyllde tio

Under torsdagen förra veckan arrangerades Life Science Swedens event New Horizons in Biologics & Bioprocessing för tionde gången.

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

Drug development creates new challenges for regulators

Nobelpris för kvantforskning i kirurgins tjänst

Tv-skärmar, LED-lampor – och medicinsk kirurgi – är områden som dragit nytta av forskningen som belönas med årets Nobelpris i kemi. Priset går till tre forskare...

Göran Stiernstedt: “We are the world’s worst at continuity”

Failed investments in primary care, an unreasonable system with online doctors and a public failure at coordinating the healthcare IT system. Göran Stiernstedt ...

Swedish pavilion with healthcare companies at Ukraine fair – “Ukraine is being rebuilt right now”

Private companies and public authorities are both needed in the reconstruction of Ukraine, said Minister for Health Care, Acko Ankarberg Johansson, in her openi...

Elicera develops CAR-T against solid tumours – may become the first in the world

Today, there are five EU-approved CAR-T therapies, all focused on different types of blood cancer, but no one has yet succeeded in making the method work agains...

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...

Här är läkemedelsföretagen som är bäst förberedda på AI

Hur väl förberedda är läkemedelsföretag inom området artificiell intelligens? Det framgår av en ny utvärdering.

Astra Zeneca licensierar ut Crispr-teknologi

Det amerikanska Crispr-bolaget Synthego kommer att få tillgång till ett genredigeringsenzym från Astra Zeneca genom ett nytecknat licensavtal.

The first vaccine derived from cowpox

The British rural doctor could not forget the words of the peasant girl. Could that really be true? A couple of decades later, on 14 May 1796, he performed the ...

Storförvärv ska öka Novo Nordisks produktionskapacitet

Novo Holding, största ägare i danska läkemedelsjätten Novo Nordisk, förvärvar den amerikanska kontraktstillverkaren Catalent i en affär på 16,5 miljarder dollar...

Lundbeck behind the first EU-approved intravenous migraine treatment

A preventive, intravenous treatment for migraines has been approved in the EU for the first time.

Swedish and Ukrainian Medical Product Agencies sign an agreement

The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.

Ny specialtidning och nytt event i Köpenhamn – Det händer hos Life Science Sweden 2024

Det nya året bjuder på nyheter för Life Science Swedens läsare.

”Newsify your equity story!”

En uppmaning till noterade life science-bolag att uppgradera sin kommunikation från ”plikt” till värdebyggare

Webinar: What is Regulatory Affairs?

This webinar is intended for those who work within the life science sector and would like to gain a general understanding of regulatory affairs for human medicinal products.

Sweden is organising a large life science conference as part of the EU presidency

On 26-27 June, Sweden will host a European meeting on life science.

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.

New diagnostic test soon ready for the market